Skip to main content
Bliss GVS Pharma Limited logo

Bliss GVS Pharma Limited — Investor Relations & Filings

Listed
Ticker · BLISSGVS ISIN · INE416D01022 LEI · 335800GXY3YCGGP7KJ45 BSE.NS Manufacturing
Open in API
Filings indexed 1,261 across all filing types
Latest filing 2026-06-23 Notice of Dividend Amou…
Country IN India
Listing BSE.NS BLISSGVS · 2 venues

About Bliss GVS Pharma Limited

https://blissgvs.com/

Bliss GVS Pharma Limited specializes in the development, manufacturing, and marketing of diverse pharmaceutical formulations. The company is a global leader in the production of suppositories and pessaries, maintaining an extensive portfolio within these specialized dosage forms. Its therapeutic focus includes anti-malarials, anti-fungals, anti-bacterials, anti-inflammatories, and gastrointestinal treatments. The organization operates state-of-the-art manufacturing facilities compliant with international quality standards, including WHO-GMP. With a strategic focus on emerging markets, the company distributes its range of prescription and over-the-counter products across Sub-Saharan Africa, Southeast Asia, and Latin America, leveraging a robust supply chain to provide accessible healthcare solutions.

Recent filings

Filing Released Lang Actions
Updates
Notice of Dividend Amount Classification · 85% confidence The document is an official notification titled 'Intimation of Book Closure and Record Date' sent to stock exchanges, mentioning Book Closure dates, Record Date for dividend payment, and referencing the 41st Annual General Meeting (AGM) for the financial year ended March 31, 2026. It does not contain any financial statements, detailed financial performance, or management analysis. The document’s length is short (3072 characters) and it mainly informs shareholders of administrative dates related to the upcoming AGM and dividend. Therefore, it is not an Annual Report, Earnings Release, or any detailed financial disclosure. The content aligns with announcements related to dividend and meeting record dates but does not announce dividend amounts or payment details explicitly; rather, it notifies about book closure and record date for the AGM and dividend payment approval. The closest fitting category is Notice of Dividend Amount (DIV) because it involves the record date for dividend payment tied with the AGM, which is customary for such notices. However, the dividend amount is not explicitly stated, only the final dividend payment timing is mentioned contingent on AGM approval, so it could arguably be a Regulatory Filing (RNS). Given the subject line and focus on book closure and record dates, the Notice of Dividend Amount (DIV) category best fits since it involves notification related to dividend payment process and key dates.
2026-06-23 English
Record Date
Notice of Dividend Amount Classification · 95% confidence The document is a formal communication addressed to stock exchanges and regulatory entities about the book closure and record date for the company's 41st Annual General Meeting (AGM) and the payment of a final dividend for the financial year ended March 31, 2026. It refers specifically to compliance with SEBI regulations and the Companies Act. The document informs about administrative dates related to shareholder records and dividend payment but does not contain detailed financial results, dividend amount specifics beyond timing, or any voting results. It is essentially an announcement of corporate actions tied to the AGM date and dividend payment, not the AGM itself, nor detailed dividend declaration or financial reports. Hence, the document best fits the "Notice of Dividend Amount" category as it informs shareholders about dividend payment timing contingent on AGM approval, and includes record date and book closure information, which is typical for dividend notices.
2026-06-23 English
Shareholders meeting
AGM Information Classification · 95% confidence The document is a Notice of the 41st Annual General Meeting (AGM) for Bliss GVS Pharma Limited. It details the date and mode of the AGM, the agenda items such as adoption of financial statements, declaration of dividend, and director re-appointment. It includes regulatory references such as SEBI regulations and Companies Act provisions relevant to AGM notices. The text repeatedly identifies itself as a Notice of AGM, including logistics for remote voting and attendance, but does not contain the full Annual Report, financial statements, or management discussion and analysis. The document length indicates it is not a minimalist announcement but the actual meeting Notice and related details. This fits the definition of AGM Information (AGM-R) as it contains the presentation and materials shared during or for the AGM but is not the Annual Report itself. Therefore, classification as AGM Information (AGM-R) is most appropriate with high confidence.
2026-06-23 English
Please find enclosed herewith the intimation regarding the Fixation of the record date for the payment of the final dividend for the financial year ended March 31, 2026.
Notice of Dividend Amount Classification · 95% confidence The document is a formal communication addressed to stock exchanges about the book closure dates and record date for the payment of final dividend and the Annual General Meeting (AGM) of Bliss GVS Pharma Ltd. It specifies the closure period for the register of members and record date for dividend payment related to the financial year ended March 31, 2026. The text indicates this is an intimation or announcement rather than a detailed report or financial statement. There is no financial data or detailed discussion of financial performance. The content is consistent with a Notice of Dividend Amount and associated AGM schedule announcement.
2026-06-23 English
Please find enclosed herewith the intimation for the Book Closure for the purpose of 41st Annual General Meeting of the Company.
Notice of Dividend Amount Classification · 95% confidence The document contains a formal notice from Bliss GVS Pharma Ltd. addressed to stock exchanges regarding the book closure and record date for the upcoming 41st Annual General Meeting (AGM) and payment of final dividend for the fiscal year ending March 31, 2026. It explicitly mentions the purpose as the AGM and dividend payment and provides no actual financial statements or detailed report content. The length is relatively short (3072 characters), and the content clearly serves as an announcement of administrative dates related to shareholder meetings and dividends rather than the detailed report itself. Therefore, it fits the category of 'Notice of Dividend Amount' since it gives information on the dividend payment date and record date associated with the AGM for the dividend year ending 2026-03-31.
2026-06-23 English
Please find enclosed herewith the Notice of 41st AGM of Bliss GVS Pharma Limited ("the Company") scheduled to be held on Wednesday, July 15, 2026, at 11:00 A.M. (IST) through VC/OAVM. The ....
AGM Information Classification · 95% confidence The document contains a formal notice addressed to stock exchanges about the upcoming 41st Annual General Meeting (AGM) of Bliss GVS Pharma Limited, including the date, time, and venue (virtual). It includes the agenda items such as adoption of financial statements, declaration of dividend, and re-appointment of a director. It also references regulatory compliance under SEBI Listing Regulations and the Companies Act 2013. The document explicitly states it is a 'Notice of the 41st Annual General Meeting' and contains detailed procedural notes for shareholders. It also mentions that the Annual Report for the year 2025-2026 is available on the company website but does not itself contain the full financial statements or in-depth management analysis. The content fits squarely the definition of AGM Information (AGM-R) as it is the notice and related information provided to shareholders for the AGM, not the full Annual Report itself or dividend declaration standalone. Furthermore, the document length (over 15,000 chars) is consistent with an AGM notice that includes substantial procedural details.
2026-06-23 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.